Boston Scientific touts CMS reimbursement nod for asthma treatment | Regulatory Roundup


Boston Scientific Corp.’s (NYSE:BSX) Alair asthma management system won reimbursement from the Centers for Medicare & Medicaid Services, effective at the start of this year.

The Alair system delivers precise thermal energy lung to tissue via bronchoscope to reduce excessively smooth muscle, decreasing the airway’s ability to constrict.

The federal agency granted the Alair device approval for Medicare reimbursement through a separate "pass-through" payment when the procedure is performed in outpatient settings, the Natick, Mass.-based med-tech titan announced.

Sign up to get our free newsletters delivered right to your inbox

The approval allows hospitals to receive payment for the Alair catheter in addition to Medicare payment for the bronchial thermoplasty procedure, according to a press release.

"CMS’ decision that the Alair bronchial thermoplasty system meets the criteria for transitional pass-through payment is a very positive development for severe asthmatics and the pulmonary physician community," BSX endoscopy division president David Pierce said in prepared remarks."It supports what we have confirmed through our clinical trials:  bronchial thermoplasty offers a new advancement in the treatment of patients with severe asthma who are not well controlled despite taking recommended doses of asthma medications.  This decision also sets an important precedent for health care payers throughout the United States."

Boston Scientific added the Alair system to its portfolio when it acquired Asthmatx Inc. for $194 million in Sept. 2010. Alair won FDA approval in April 2010, becoming the first device-based asthma treatment approved by the watchdog agency.

Regulatory Roundup

BioMimetic’s bone graft PMA gets a no-go from the FDA
The federal watchdog agency did not approve the pre-market approval application for BioMimetic Therapeutics’ Augment bone graft, even after an independent advisory panel voted in the product’s favor. Read more

AirStrip lands CE Mark for mobile monitoring system
San Antonio, Texas-based AirStrip Technologies won CE Mark approval for its flagship mobile patient monitoring systems. The AirStrip OB, AirStrip Cardiology and AirStrip Patient Monitoring systems are all available for use by European clinicians. Read more

Ultrasound stroke treatment wins CE Mark
Cerevast Therapeutics landed CE Mark approval for its Clotbust ER SonoLysis system to treat ischemic stroke in emergency settings. Read more

FDA approves Cyberonics AspireHC generator
The federal watchdog agency cleared the re-design of Cyberonics Inc.’s AspireHC generator. The VNS therapy treatment was the subject of a voluntary recall in August 2011. Read more

Enteromedics completes enrollment of clinical trials
St. Paul, Minn.-based Enteromedics completed patient enrollment of the ReCharge trial for its VBloc vagal blocking therapy. The random, double-blind, parallel-group study will consist of 233 patients in the U.S. and Australia. Read more

ThermoGenesis wins approval in India
ThermoGenesis Corp. landed approval from India’s Ministry of Health for its AutoXpress system for the processing of stem cells from cord blood. Read more

BioLineRx initiates registration trial for BCM
Biopharmaceutical development company BioLineRx initiated the CE mark registration trial of its BCM (BL-1040) system, a medical device to prevent cardiac remodeling following acute myocardial infarctions. Read more

RSS From Medical Design & Outsourcing

  • Cyberdyne CEO has severed spines on his agenda
    Editor’s Note: This article is from‘s Natasha Khan. Cyberdyne Inc.’s CEO, Yoshiyuki Sankai, is researching ways to repair damaged body tissue. The 57-year-old scientist’s vision: to treat patients with spinal injuries by using stem-cell related technology to repair nerve connections and robotic suits that aid movement. Sankai’s company is setting its sights on better […]
  • Teknor Apex to showcase wide range of PVC compounds for medical devices at Medtec China
    Building on its international leadership role as a supplier of medical-grade PVC compounds, Teknor Apex Company has developed flexible and rigid formulations that address the special needs of device manufacturers. The company will highlight these capabilities at Medtec China 2015. “Teknor Apex produces or markets medical-grade PVC compounds in China, Singapore, Europe, and the United […]
  • The Raspberry Pi eco-system goes interstellar with the new Raspberry Pi Sense HAT
    Newark element14 has globally launched the latest addition to the expanding ecosystem of Raspberry Pi accessories, the Raspberry Pi Sense HAT, as featured in the ‘Astro Pi’ space mission. The Sense HAT will enable enthusiasts to control the same hardware used in space. The Sense HAT attaches to the Raspberry Pi board, and can be […]
  • CommScope completes acquisition of TE Connectivity’s Telecom
    CommScope Holding Company, has completed its previously announced acquisition of TE Connectivity’s Telecom, Enterprise and Wireless businesses, a leader in fiber optic connectivity for wireline and wireless networks. The all-cash transaction, valued at approximately $3 billion, strengthens CommScope’s position as a leading communications infrastructure provider with deeper resources to meet the world’s growing demand for network […]
  • SPI awards IKO Prosthetic Creative System the Student Design International Design Excellence Award
    SPI: The Plastics Industry Trade Association congratulated IKO Prosthetic Creative System for winning the SPI Student Design Award, part of the Industrial Designers Society of America’s (IDSA’s) International Design Excellence Awards (IDEA) program. The award was presented to IKO, an innovative, youth-focused prosthetic design company led by Chicago-based designer Carlos Torres, by SPI’s Senior Director of […]
  • New assay could revolutionize diagnosis and treatment of life-threatening disease
    Invasive Fungal Disease (IFD) is an emerging global health problem associated with high mortality rates in severely immunocompromised patients, such as those undergoing intensive chemotherapy or stem cell transplantation, and in patients suffering immune compromising conditions such as AIDS. The most common causative agents of this disease have been identified as Candida and Aspergillus species, […]
  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]

Leave a Reply